Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma

Published:2018-12-13 Issue:6 Volume:33 Page:536-541
ISSN:0894-1939
Container-title:Journal of Investigative Surgery
language:en
Short-container-title:Journal of Investigative Surgery

Author:

Maimaitiming Abuduaiheti¹,Zhou Xing¹,Ma Xianxiong²,Huang Yongming²,Wang Qingbo²,Deng Rui²,Ren Yahui²,Chai Xinqun¹,Zhang Pei²

Affiliation:

1. Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;

2. Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Funder

Natural Science Foundation of Hubei Province

Foundation of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Publisher

Informa UK Limited

Subject

Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/08941939.2018.1535009

Reference25 articles.

1. Global Epidemiology of Hepatocellular Carcinoma

2. Focus on hepatocellular carcinoma

3. Novel Systemic Therapy Options for Hepatocellular Carcinoma

4. Systemic treatment of hepatocellular carcinoma

5. Updated treatment approach to hepatocellular carcinoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma CD24 level as a promising prognostic biomarker of hepatocellular carcinoma;Egyptian Liver Journal;2024-05-23

2. Checkpoint CD24 function on tumor and immunotherapy;Frontiers in Immunology;2024-02-29

3. CD24 blockade as a novel strategy for cancer treatment;International Immunopharmacology;2023-08

4. Identification of biomarkers of hepatocellular carcinoma gene prognosis based on the immune-related lncRNA signature of transcriptome data;Functional & Integrative Genomics;2023-03-28

5. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer;Cells;2023-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3